Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Prolymphocyctic Leukemia: early-phase trial registry

1 of 1 indexed Prolymphocyctic Leukemia trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Prolymphocyctic Leukemia: 1 US clinical trial tracked, 1 recruiting.

Prolymphocyctic Leukemia is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Center for International Blood and Marrow Transplant Research, running 1 of these trials.

Enrollment posture brief

Registry condition prolymphocyctic-leukemia

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Prolymphocyctic Leukemia (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Prolymphocyctic Leukemia

Prolymphocyctic Leukemia lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Prolymphocyctic Leukemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Prolymphocyctic Leukemia is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Prolymphocyctic Leukemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Conditioning Regimen E Drug
1 trials
Conditioning Regimen D Drug
1 trials
Conditioning Regimen C Drug
1 trials
Conditioning Regimen B Drug
1 trials
Conditioning Regimen A Drug
1 trials

US sites by state

Facility locations filed on Prolymphocyctic Leukemia trials. A trial with sites in several states counts in each.

Washington 1 trials
Virginia 1 trials
Texas 1 trials
Oregon 1 trials
New York 1 trials
North Carolina 1 trials
Michigan 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Prolymphocyctic Leukemia page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Prolymphocyctic Leukemia condition card totals 1 registered trials; most-linked intervention Conditioning Regimen E; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.